Join
Live feed
·
NEWSReleasevia Quantisnow
Sorrento Therapeutics Inc. logo
Vickers Vantage Corp. I logo

Sorrento's Scilex Initiates Phase 2 Study To Evaluate Safety And Efficacy Of SP-103 In Subjects With Acute Low Back Pain

ByQuantisnow·Wall Street's wire, on your screen.
SRNE· Sorrento Therapeutics Inc.VCKA· Vickers Vantage Corp. I
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRNE (Sorrento Therapeutics Inc.), VCKA (Vickers Vantage Corp. I) and more on Quantisnow.